PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 71 filers reported holding PASSAGE BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $31,809,000 | -36.2% | 5,009,219 | 0.0% | 2.45% | -38.7% |
Q3 2021 | $49,892,000 | -24.8% | 5,009,219 | 0.0% | 3.99% | -34.7% |
Q2 2021 | $66,322,000 | -24.3% | 5,009,219 | 0.0% | 6.12% | -12.9% |
Q1 2021 | $87,561,000 | -31.6% | 5,009,219 | 0.0% | 7.02% | -28.8% |
Q4 2020 | $128,086,000 | +95.0% | 5,009,219 | 0.0% | 9.86% | +67.3% |
Q3 2020 | $65,671,000 | -52.0% | 5,009,219 | 0.0% | 5.90% | -51.0% |
Q2 2020 | $136,902,000 | +73.5% | 5,009,219 | 0.0% | 12.02% | +34.4% |
Q1 2020 | $78,895,000 | – | 5,009,219 | – | 8.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
Annandale Capital, LLC | 54,338 | $51 | 0.02% |